Austar Lifesciences Limited (HKG:6118)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7350
+0.0050 (0.68%)
Sep 11, 2026, 9:31 AM HKT

Austar Lifesciences Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
209.69227.39166.81163.77133.62198.45
Short-Term Investments
--11014.5121.29
Cash & Short-Term Investments
209.69227.39167.81173.77148.13219.74
Cash Growth
26.58%35.51%-3.43%17.31%-32.59%23.37%
Accounts Receivable
990.45979.83987.01994.691,000672.83
Other Receivables
-12.131.3126.1320.0127.59
Receivables
990.45991.931,0181,0211,020700.42
Inventory
288.53279.65238.43243.16388.11423.26
Other Current Assets
137.38114.74127.21136.08244.35319.82
Total Current Assets
1,6261,6141,5521,5741,8011,663
Property, Plant & Equipment
395.05392.82414.13443.85433.61311.81
Long-Term Investments
68.7266.5960.2882.1185.539.7
Other Intangible Assets
37.3340.3942.342.4755.8721.11
Long-Term Deferred Tax Assets
11.1112.3815.1716.7212.788.92
Other Long-Term Assets
1.422.11----
Total Assets
2,1402,1282,0842,1592,3892,045

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
540.25460.35382.11405.93426.2352.35
Accrued Expenses
89.587.48111.27114.22180.93155.36
Short-Term Debt
150.5237.62229.75255.31173.5556.09
Current Portion of Long-Term Debt
4320.7898.8864.5245.67-
Current Portion of Leases
9.4711.7916.9813.3814.389.97
Current Income Taxes Payable
3.343.71.540.855.155.72
Current Unearned Revenue
237.92260.34202.26180.19382.71466.69
Other Current Liabilities
124.48106.02145.89143.29131.1790.02
Total Current Liabilities
1,1981,1881,1891,1781,3601,136
Long-Term Debt
57.1663.2325.14110.8540.0754.27
Long-Term Leases
8.1210.2631.252.1462.8734.89
Long-Term Unearned Revenue
0.260.470.140.340.540.75
Long-Term Deferred Tax Liabilities
42.3841.8940.1837.8437.7430.25
Other Long-Term Liabilities
--4.834.644.19-
Total Liabilities
1,3061,3041,2901,3831,5051,256

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
4.074.074.074.074.074.07
Additional Paid-In Capital
-342.68339.55339.55339.55344.16
Retained Earnings
373.77435.18401.37385.29498.77411.31
Comprehensive Income & Other
453.5440.6246.4144.0954.5527.05
Total Common Equity
831.38822.55791.41773.01896.94786.58
Minority Interest
1.941.542.062.46-13.361.84
Shareholders' Equity
833.32824.09793.47775.47883.58788.42
Total Liabilities & Equity
2,1402,1282,0842,1592,3892,045

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
268.24343.68401.95496.2336.55155.22
Net Cash (Debt)
-58.55-116.28-234.15-322.43-188.4264.52
Net Cash Growth
------36.53%
Net Cash Per Share
-0.11-0.23-0.46-0.63-0.370.13
Filing Date Shares Outstanding
512.58512.58512.58512.58512.58512.58
Total Common Shares Outstanding
512.58512.58512.58512.58512.58512.58
Working Capital
427.6425.64363.08396.13441.24527.05
Book Value Per Share
1.621.601.541.511.751.53
Tangible Book Value
794.05782.15749.11730.54841.08765.47
Tangible Book Value Per Share
1.551.531.461.431.641.49
Buildings
-267.66267.41249.4117.3716.62
Machinery
-86.1584.8892.5780.675.1
Construction In Progress
-15.785.034.51214.04135.56
Order Backlog
-1,1281,0821,0141,4421,593